Skip to main content
TipRanks
Go Ultimate75% OFF

Veradermics, Incorporated (MANE) Stock Statistics & Valuation Metrics

91 Followers

Total Valuation

Veradermics, Incorporated has a market cap or net worth of $5.47B. The enterprise value is $4.32B.

Market Cap
$5.47B
Enterprise Value
$4.32B

Share Statistics

Veradermics, Incorporated has 42,195,473 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
42,195,473
Owned by Insiders
16.66%
Owned by Institutions
29.71%

Financial Efficiency

Veradermics, Incorporated’s return on equity (ROE) is 0.58 and return on invested capital (ROIC) is -50.43%.

Return on Equity (ROE)
0.58
Return on Assets (ROA)
-0.46
Return on Invested Capital (ROIC)
-50.43%
Return on Capital Employed (ROCE)
-0.50
Revenue Per Employee
0
Profits Per Employee
-1.37M
Employee Count
51
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Veradermics, Incorporated is -49.11. Veradermics, Incorporated’s PEG ratio is 1.28.

PE Ratio
-49.11
PS Ratio
0.00
PB Ratio
6.86
Price to FCF
-66.23
Price to Operating Cash Flow
-66.41
PEG Ratio
1.28

Income Statement

In the last 12 months, Veradermics, Incorporated had revenue of 0 and earned -70.00M in profits. Earnings per share was -111.91.

Revenue
0
Gross Profit
0
Operating Income
-72.35M
Pretax Income
-70.00M
Net Income
-70.00M
EBITDA
-70.00M
Earnings Per Share (EPS)
-111.91

Cash Flow

In the last 12 months, operating cash flow was -82.23M and capital expenditures -372,000, giving a free cash flow of -82.60M billion.

Operating Cash Flow
-82.23M
Free Cash Flow
-82.60M
Free Cash Flow per Share
-1.96

Dividends & Yields

Veradermics, Incorporated pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-1.51%
Earnings Yield
-1.71%

Stock Price Statistics

Beta
0.19
52-Week Price Change
243.47%
50-Day Moving Average
122.23
200-Day Moving Average
96.14
Relative Strength Index (RSI)
48.04
Average Volume (3m)
755.78K

Important Dates

Veradermics, Incorporated upcoming earnings date is Apr 05, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 10, 2026
Next Earnings Date
Apr 05, 2027
Ex-Dividend Date
―

Financial Position

Veradermics, Incorporated as a current ratio of 16.66, with Debt / Equity ratio of -0.00%

Current Ratio
16.66
Quick Ratio
16.66
Debt to Market Cap
0.00
Net Debt to EBITDA
0.31
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Veradermics, Incorporated has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Veradermics, Incorporated EV to EBITDA ratio is -53.88, with an EV/FCF ratio of -64.64.

EV to Sales
0.00
EV to EBITDA
-53.88
EV to Free Cash Flow
-64.64
EV to Operating Cash Flow
-64.93

Balance Sheet

Veradermics, Incorporated has $798.35M in cash and marketable securities with $668.00K in debt, giving a net cash position of $797.68M billion.

Cash & Marketable Securities
$798.35M
Total Debt
$668.00K
Net Cash
$797.68M
Net Cash Per Share
$18.90
Tangible Book Value Per Share
$18.91

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Veradermics, Incorporated is $180.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$180.67
Price Target Upside
39.34% Upside
Analyst Consensus
Strong Buy
Analyst Count
3
Revenue Growth Forecast
―
EPS Growth Forecast
-57.61%

Scores

Smart Score
8
AI Score
54